The selection process
Where it all begins
Medicinal plants form the basis of all our herbal medications.
Selection and analysis
Selecting the best plants is a time-consuming process, as it involves analysing the active ingredient profiles of numerous different varieties.
More information about how we select our medicinal plants is available on the website of our subsidiary Vitaplant AG (www.vitaplant.ch).
Cultivation of medicinal plants
Good Agricultural Practice
After the patenting process, large-scale cultivation of the plants begins in adherence with the Good Agricultural Practice guidelines.
The cultivation of our raw materials is subject to strict quality standards. We monitor every aspect that can have an impact on quality, such as the seeds and fertilisation methods, as well as the harvesting time and technique. We avoid using synthetic pesticides wherever possible.
Our seamless documentation means that our raw plant materials can be traced all the way back to the field.
During the production process, the active ingredients are extracted from the plants using a mixture of alcohol and water.
Good Manufacturing Practice
All stages of production are carried out in accordance with the pharmaceutical GMP standard (Good Manufacturing Practice) in order to ensure the greatest possible consistency and quality.
Tableting and packaging
The dried extract is mixed with various pharmaceutical excipients and pressed into film-coated tablets.
Film-coated tablets make it possible to accurately dose the active ingredients and ensure they remain stable for long periods of time.
Quality management and quality control are among the most important competencies of any pharmaceutical company. Our products and raw materials are monitored using the latest analytical laboratory techniques.
This guarantees the safety and effectiveness of the finished products.
Research and clinical trials
Before clinical trials involving test subjects can take place, the effectiveness and harmlessness of the extracts are tested in a laboratory.
Effectiveness and safety
During the clinical trials, the effectiveness and safety of the medicines is compared with that of placebos, as well as other standard treatments.
The results of these trials are regularly published in internationally recognised and independent (peer-reviewed) journals.
Public health authority
Before a medication can be sold in Switzerland, it must first be approved by Swissmedic.
Before approval is granted, the manufacturer must prove that its medication is safe, effective and economically viable.